Assembly Biosciences (ASMB) Interest Expenses (2010 - 2011)

Assembly Biosciences (ASMB) recorded quarterly Interest Expenses of -$302327.0 in Q4 2011, down 206.49% quarter-over-quarter from $283907.0 in Q3 2011, and up 86.63% on a YoY basis from -$161989.4 in Q4 2010.

Assembly Biosciences (ASMB) Interest Expenses (2010 - 2011) Analysis & Trends

Assembly Biosciences' Interest Expenses history runs 2 years deep, the most recent figure standing at -$302327.0 for Q4 2011.

  • In Q4 2011, Interest Expenses rose 86.63% year-over-year to -$302327.0; the TTM figure through Sep 2012 stood at -$302327.0 (up 83.81% YoY), while the FY2011 annual figure was $116664.0, down 94.29% from the prior year.
  • Interest Expenses was -$302327.0 for Q4 2011 at Assembly Biosciences, down from $283907.0 in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $1.3 million in Q3 2010 to a low of -$2.3 million in Q4 2010.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int Expense (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -5.50 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -332,000.00
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 61,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -2,753.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -5.58 Mn
10 Assembly Biosciences 418.96 Mn 192.36 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2011 -302,327.00
Dec 31, 2011 -302,327.00
Sep 30, 2011 283,907.00
Sep 30, 2011 283,907.00
Jun 30, 2011 65,907.00
Jun 30, 2011 65,907.00
Mar 31, 2011 44,663.00
Mar 31, 2011 44,663.00
Dec 31, 2010 -2.26 Mn
Dec 31, 2010 -2.26 Mn
Sep 30, 2010 1.27 Mn
Sep 30, 2010 1.27 Mn
Jun 30, 2010 684,457.00
Jun 30, 2010 684,457.00